158 related articles for article (PubMed ID: 22899340)
61. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1.
Peng M; Lundgren E
Leukemia; 1993 Jan; 7(1):104-12. PubMed ID: 8093369
[TBL] [Abstract][Full Text] [Related]
62. CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.
Kuzmina Z; Krenn K; Petkov V; Körmöczi U; Weigl R; Rottal A; Kalhs P; Mitterbauer M; Ponhold L; Dekan G; Greinix HT; Pickl WF
Blood; 2013 Mar; 121(10):1886-95. PubMed ID: 23303823
[TBL] [Abstract][Full Text] [Related]
63. Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias.
Lad DP; Varma S; Varma N; Sachdeva MU; Bose P; Malhotra P
Leuk Lymphoma; 2015; 56(8):2424-8. PubMed ID: 25393804
[TBL] [Abstract][Full Text] [Related]
64. Cell-specific expression of the murine CD21 gene depends on accessibility of promoter and intronic elements.
Zabel MD; Byrne BL; Weis JJ; Weis JH
J Immunol; 2000 Oct; 165(8):4437-45. PubMed ID: 11035082
[TBL] [Abstract][Full Text] [Related]
65. Very low levels of surface CD45 reflect CLL cell fragility, are inversely correlated with trisomy 12 and are associated with increased treatment-free survival.
Rizzo D; Lotay A; Gachard N; Marfak I; Faucher JL; Trimoreau F; Guérin E; Bordessoule D; Jaccard A; Feuillard J
Am J Hematol; 2013 Sep; 88(9):747-53. PubMed ID: 23733486
[TBL] [Abstract][Full Text] [Related]
66. The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes.
Till KJ; Lin K; Zuzel M; Cawley JC
Blood; 2002 Apr; 99(8):2977-84. PubMed ID: 11929789
[TBL] [Abstract][Full Text] [Related]
67. Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS).
Garcia C; Rosén A; Kimby E; Aguilar-Santelises M; Jondal M; Bjorkholm M; Holm G; Mellstedt H
Leuk Res; 1989; 13(1):31-7. PubMed ID: 2536870
[TBL] [Abstract][Full Text] [Related]
68. B-zone small lymphocytic lymphoma: a morphologic, immunophenotypic, and clinical study with comparison to "well-differentiated" lymphocytic disorders.
Carbone A; Pinto A; Gloghini A; Volpe R; Zagonel V
Hum Pathol; 1992 Apr; 23(4):438-48. PubMed ID: 1563746
[TBL] [Abstract][Full Text] [Related]
69. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
70. [Lymphocyte proliferation and differentiation in chronic lympholeukemia].
Kogarko IN
Eksp Onkol; 1990; 12(5):43-9. PubMed ID: 2226258
[TBL] [Abstract][Full Text] [Related]
71. Ectonucleoside triphosphate diphosphohydrolase-1 (E-NTPDase1/CD39) as a new prognostic marker in chronic lymphocytic leukemia.
Abousamra NK; Salah El-Din M; Hamza Elzahaf E; Esmael ME
Leuk Lymphoma; 2015 Jan; 56(1):113-9. PubMed ID: 24684231
[TBL] [Abstract][Full Text] [Related]
72. Tumor necrosis factor alpha promoter polymorphism and the risk of chronic lymphocytic leukemia and myeloma in the Chinese population.
Au WY; Fung A; Wong KF; Chan CH; Liang R
Leuk Lymphoma; 2006 Oct; 47(10):2189-93. PubMed ID: 17071494
[TBL] [Abstract][Full Text] [Related]
73. [Immunophenotype of neoplastic cells and its clinical significance in chronic lymphocytic leukemia].
Nikitin EN; Ovchinina NG; Shishkin AV; Kir'ianov NA
Vestn Ross Akad Med Nauk; 2010; (7):19-22. PubMed ID: 20795398
[TBL] [Abstract][Full Text] [Related]
74. [THE COMBINATION OF EXPRESSION OF MARKERS CR1 AND CR2 (CD35/CD21) IN DIAGNOSTIC OF B-CELL LYMPHOPROLIFERATIVE DISEASES].
Chibisova ON; Burtsev DV; Galstian KM; Lugovskaia GI
Klin Lab Diagn; 2015 Apr; 60(4):50-2. PubMed ID: 26189291
[TBL] [Abstract][Full Text] [Related]
75. Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation.
Barrena S; Almeida J; Yunta M; López A; Fernández-Mosteirín N; Giralt M; Romero M; Perdiguer L; Delgado M; Orfao A; Lazo PA
Leukemia; 2005 Aug; 19(8):1376-83. PubMed ID: 15931266
[TBL] [Abstract][Full Text] [Related]
76. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
[TBL] [Abstract][Full Text] [Related]
77. Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23.
Debnath I; Roundy KM; Weis JJ; Weis JH
Mol Immunol; 2007 Mar; 44(9):2388-99. PubMed ID: 17140663
[TBL] [Abstract][Full Text] [Related]
78. Epstein-Barr viruses that express a CD21 antibody provide evidence that gp350's functions extend beyond B-cell surface binding.
Busse C; Feederle R; Schnölzer M; Behrends U; Mautner J; Delecluse HJ
J Virol; 2010 Jan; 84(2):1139-47. PubMed ID: 19889766
[TBL] [Abstract][Full Text] [Related]
79. Aberrant TIRAP and MyD88 expression in B-cell chronic lymphocytic leukemia.
Antosz H; Sajewicz J; Marzec-Kotarska B; Dmoszyńska A; Baszak J; Jargiełło-Baszak M
Blood Cells Mol Dis; 2013 Jun; 51(1):48-55. PubMed ID: 23419703
[TBL] [Abstract][Full Text] [Related]
80. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
